Where Biomedical Innovation Meets Real-World Impact
The Master of Biomedical Innovation (MBI) program is a multidisciplinary, project-oriented graduate program focused on bridging the gap between technology development and its transfer into local, national, and international biomedical markets. By linking the theory and practice of the biomedical innovation process, the program delivers a systematic but responsive approach to the critical, emerging discipline of innovation and entrepreneurship (I&E).
Information Box Group
Expected Outcomes
Students of the program will:
- Learn how to create and market biomedical products or devices.
- Network and learn from renowned inventors and innovators.
- Better understand emerging opportunities in therapeutics, artificial intelligence (AI), medtech, and more.
Admissions Now Open Apply Today
Admissions for the 2026/2027 academic year are open.
- International applications are now closed.
- Deadline to be eligible for one of three $2,500 scholarships is February 1, 2026.
- Domestic applications close March 14, 2026.
Your Path Through the MBI
The MBI is unique within health sciences education and is the first graduate health care entrepreneurship program of its kind in Canada. It is a graduate-level program with the curriculum divided into three phases guiding learners through the biomedical innovation and entrepreneurship process. Learners will simultaneously acquire and apply the theories and skillsets presented across the three phases to a venture-orientated project.
Term 1
Biomedical problem identification and exploration
Term 2
Solutions design and prototyping
Term 3
Business model and pitch development
Information Box Group
Get more information about the MBI and future cohorts Learn more
Interested in joining a future cohort of health innovators? Discover program details, application timelines, and what to expect from the Master of Biomedical Innovation as you prepare to take the next step in your career.